行情

HCM

HCM

和黄医药
NASDAQ

实时行情|Nasdaq Last Sale

23.48
+0.34
+1.47%
盘后: 23.46 -0.02 -0.09% 16:09 01/24 EST
开盘
23.81
昨收
23.14
最高
24.43
最低
23.38
成交量
78.10万
成交额
--
52周最高
32.55
52周最低
16.47
市值
31.32亿
市盈率(TTM)
-356.8389
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

HCM 新闻

  • Hutchison China MediTech Limited Just Released Its Third-Quarter Earnings: Here's What Analysts Think
  • Simply Wall St..2天前
  • Chi-Med prices $110M equity offering
  • seekingalpha.2天前
  • Chi-Med Prices 4.4M Public Offering of ADSs @$25/ADS
  • Benzinga.3天前
  • Chi-Med Announces Pricing of US$110 Million Public Offering of ADSs
  • GlobeNewswire.3天前

更多

所属板块

制药
-1.84%
制药与医学研究
-2.00%

热门股票

名称
价格
涨跌幅

HCM 简况

Hutchison China Meditech Limited is an investment holding company principally engaged in the manufacture and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Manufacturing Business segment is engaged in the manufacture and distribution of drug products. The Distribution Business segment provides sales and marketing services to pharmaceutical manufacturers. The Company's products include prescription and over the counter (OTC) pharmaceuticals such as banlangen, fu fang dan shen tablets and shexiang baoxin pills and others, and consumer health products. In addition, the Company also develops targeted therapeutics and immunotherapies for oncology and autoimmune diseases.
展开

Webull提供Hutchison China MediTech Limited的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。